In contrast to control-edited T cells that showed a gradual decline in the ability to control the growth of cancer cells with each stimulation, RASA2-ablated T cells maintained their robust killing capacity after multiple stimulations (Extended Data Fig. 8a). This evidence concerns the gene RASA2 and cancer.